MSD will soon enter the market for drugs used to protect infants from respiratory syncytial virus (RSV) infections after getting approval from the FDA for its antibody therapy Enflonsia. The green ...

Looking for specific insider transactions? Use our insider trading screener to screen 1M+ transactions. All data is updated in near real-time. Visit our education center to learn more about insider ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.